Turnes J, Oyagüez I, Planas R, García-Samaniego J, Diago M, Crespo J, Calleja JL, Solà R, Casado MA, Romero-Gómez M

Cost-saving approach to triple therapy for hepatitis C using the OPTIM prognostic tool to predict virologic response to 4 weeks of peginterferon and ribavirin in genotype 1 patients

The Liver Meeting, AASLD’s 64th Annual Meeting in Washington, EEUU, 1-5 Noviembre 2013